selenocysteine has been researched along with curcumin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, J; Holmgren, A; Lu, J | 1 |
| Chen, W; Lai, Y; Liu, Y; Rein, KS; Rodriguez Del Rey, F; Rolle, S; Tuladhar, A; Zavala, CE | 1 |
2 other study(ies) available for selenocysteine and curcumin
| Article | Year |
|---|---|
Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity.
Topics: Animals; Anions; Antineoplastic Agents; Binding Sites; Cell Nucleus; Curcuma; Curcumin; Cysteine; Cytosol; Dose-Response Relationship, Drug; HeLa Cells; Humans; Inhibitory Concentration 50; Mass Spectrometry; Mitochondria; Models, Biological; Models, Chemical; NADP; NADPH Oxidases; Oxidants; Oxidation-Reduction; Peptides; Plant Extracts; Protein Binding; Rats; Selenocysteine; Superoxides; Temperature; Thioredoxin-Disulfide Reductase; Time Factors | 2005 |
Brevetoxin-2, is a unique inhibitor of the C-terminal redox center of mammalian thioredoxin reductase-1.
Topics: Animals; Cell Line; Cell Survival; Curcumin; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Lipid Peroxidation; Marine Toxins; Oxidation-Reduction; Oxocins; Protein Domains; Rats; Selenocysteine; Thioredoxin Reductase 1; Time Factors | 2017 |